• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分子特征分析揭示了小儿脊髓少突胶质细胞瘤中的NF1缺失和FGFR1激活突变。

Molecular characterization reveals NF1 deletions and FGFR1-activating mutations in a pediatric spinal oligodendroglioma.

作者信息

Bruzek Amy K, Zureick Andrew H, McKeever Paul E, Garton Hugh J L, Robertson Patricia L, Mody Rajen, Koschmann Carl J

机构信息

Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, Michigan.

Medical School, University of Michigan Medical School, Ann Arbor, Michigan.

出版信息

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26346. Epub 2016 Nov 10.

DOI:10.1002/pbc.26346
PMID:27862886
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5611838/
Abstract

Pediatric spinal oligodendrogliomas are rare and aggressive tumors. They do not share the same molecular features of adult oligodendroglioma, and no previous reports have examined the molecular features of pediatric spinal oligodendroglioma. We present the case of a child with a recurrent spinal anaplastic oligodendroglioma. We performed whole exome (paired tumor and germline DNA) and transcriptome (tumor RNA) sequencing, which revealed somatic mutations in NF1 and FGFR1. These data allowed us to explore potential personalized therapies for this patient and expose molecular drivers that may be involved in similar cases.

摘要

小儿脊髓少突胶质细胞瘤是罕见的侵袭性肿瘤。它们不具有成人少突胶质细胞瘤相同的分子特征,且此前没有关于小儿脊髓少突胶质细胞瘤分子特征的报道。我们报告了一例复发性脊髓间变性少突胶质细胞瘤患儿的病例。我们进行了全外显子组(配对的肿瘤和胚系DNA)及转录组(肿瘤RNA)测序,结果显示NF1和FGFR1存在体细胞突变。这些数据使我们能够探索针对该患者的潜在个性化治疗方法,并揭示可能与类似病例相关的分子驱动因素。

相似文献

1
Molecular characterization reveals NF1 deletions and FGFR1-activating mutations in a pediatric spinal oligodendroglioma.分子特征分析揭示了小儿脊髓少突胶质细胞瘤中的NF1缺失和FGFR1激活突变。
Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26346. Epub 2016 Nov 10.
2
Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors.液滴数字PCR是一种强大的技术,可用于证明胚胎发育不良性神经上皮肿瘤中FGFR1频繁重复。
Oncotarget. 2017 Jan 10;8(2):2104-2113. doi: 10.18632/oncotarget.12881.
3
Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1.菊形团形成性神经胶质神经元肿瘤具有独特的 DNA 甲基化谱和 FGFR1 突变,常伴有 PIK3CA 和 NF1 的共突变。
Acta Neuropathol. 2019 Sep;138(3):497-504. doi: 10.1007/s00401-019-02038-4. Epub 2019 Jun 27.
4
Identification and targeting of an FGFR fusion in a pediatric thalamic "central oligodendroglioma".小儿丘脑“中心性少突胶质细胞瘤”中FGFR融合的鉴定与靶向治疗
NPJ Precis Oncol. 2017 Sep 7;1(1):29. doi: 10.1038/s41698-017-0036-8. eCollection 2017.
5
ETV/Pea3 family transcription factor-encoding genes are overexpressed in CIC-mutant oligodendrogliomas.ETV/Pea3家族转录因子编码基因在CIC突变型少突胶质细胞瘤中过表达。
Genes Chromosomes Cancer. 2015 Dec;54(12):725-33. doi: 10.1002/gcc.22283. Epub 2015 Sep 10.
6
Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma.深度测序结合表达和功能分析揭示 FGFR1 在尤文肉瘤中的激活。
Clin Cancer Res. 2015 Nov 1;21(21):4935-46. doi: 10.1158/1078-0432.CCR-14-2744. Epub 2015 Jul 15.
7
Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas.1号染色体短臂和19号染色体长臂缺失在儿童少突胶质细胞瘤中罕见。
Acta Neuropathol. 2005 Apr;109(4):387-92. doi: 10.1007/s00401-004-0976-2. Epub 2005 Mar 1.
8
Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.少突胶质细胞瘤的分子遗传学分析显示,19号染色体长臂(19q)和1号染色体短臂(1p)存在优先等位基因缺失。
Am J Pathol. 1994 Nov;145(5):1175-90.
9
Spinal cord oligodendroglioma with 1p and 19q deletions presenting with cerebral oligodendrogliomatosis.伴有1p和19q缺失的脊髓少突胶质细胞瘤并表现为大脑少突胶质细胞增生症
J Neurosurg Spine. 2009 Jun;10(6):557-63. doi: 10.3171/2009.2.SPINE08853.
10
1p/19q chromosome deletions in metastatic oligodendroglioma.转移性少突胶质细胞瘤中的1p/19q染色体缺失
J Neurooncol. 2006 Nov;80(2):203-7. doi: 10.1007/s11060-006-9179-0. Epub 2006 May 19.

引用本文的文献

1
Current Landscape of Preclinical Models for Pediatric Gliomas: Clinical Implications and Future Directions.小儿胶质瘤临床前模型的现状:临床意义与未来方向
Cancers (Basel). 2025 Jul 2;17(13):2221. doi: 10.3390/cancers17132221.
2
A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities.《同基因、可移植儿科高级别神经胶质瘤模型概述揭示了亚型特异性治疗弱点》。
Cancer Discov. 2023 Jul 7;13(7):1592-1615. doi: 10.1158/2159-8290.CD-23-0004.
3
Clinical and molecular characterization of a multi-institutional cohort of pediatric spinal cord low-grade gliomas.

本文引用的文献

1
Targeting the fibroblast growth factor receptor family in cancer.靶向成纤维细胞生长因子受体家族治疗癌症。
Cancer Treat Rev. 2016 May;46:51-62. doi: 10.1016/j.ctrv.2016.03.015. Epub 2016 Apr 12.
2
Prolonged disease control with MEK inhibitor in neurofibromatosis type I-associated glioblastoma.MEK抑制剂在I型神经纤维瘤病相关胶质母细胞瘤中的长期疾病控制
J Clin Pharm Ther. 2016 Jun;41(3):357-359. doi: 10.1111/jcpt.12378. Epub 2016 Mar 2.
3
Spinal Anaplastic Oligodendroglioma With Oligodendrogliomatosis: Molecular Markers and Management: Case Report.
多机构队列小儿脊髓低级别胶质瘤的临床与分子特征
Neurooncol Adv. 2020 Aug 24;2(1):vdaa103. doi: 10.1093/noajnl/vdaa103. eCollection 2020 Jan-Dec.
4
Determination of genetic aberrations and novel transcripts involved in the pathogenesis of oligodendroglioma using array comparative genomic hybridization and next generation sequencing.利用阵列比较基因组杂交和新一代测序技术确定少突胶质细胞瘤发病机制中涉及的基因畸变和新转录本。
Oncol Lett. 2019 Feb;17(2):1675-1687. doi: 10.3892/ol.2018.9811. Epub 2018 Dec 7.
伴有少突胶质细胞瘤病的脊髓间变性少突胶质细胞瘤:分子标志物与治疗:病例报告
Neurosurgery. 2016 Mar;78(3):E466-73. doi: 10.1227/NEU.0000000000001019.
4
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth.青少年难治性或复发性癌症管理中的综合临床测序
JAMA. 2015 Sep 1;314(9):913-25. doi: 10.1001/jama.2015.10080.
5
Clinical management of grade III oligodendroglioma.三级少突胶质细胞瘤的临床管理
Cancer Manag Res. 2015 Jul 27;7:213-23. doi: 10.2147/CMAR.S56975. eCollection 2015.
6
Oligodendroglioma: pathology, molecular mechanisms and markers.少突胶质细胞瘤:病理学、分子机制及标志物
Acta Neuropathol. 2015 Jun;129(6):809-27. doi: 10.1007/s00401-015-1424-1. Epub 2015 May 6.
7
Treatment of an adolescent with chronic myeloid leukemia and the T315I mutation with ponatinib.用普纳替尼治疗一名患有慢性髓性白血病且携带T315I突变的青少年。
Pediatr Blood Cancer. 2015 Nov;62(11):2050-1. doi: 10.1002/pbc.25551. Epub 2015 May 4.
8
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.一种在癌症中常见突变的RAS病基因:1型神经纤维瘤病肿瘤抑制基因。
Nat Rev Cancer. 2015 May;15(5):290-301. doi: 10.1038/nrc3911. Epub 2015 Apr 16.
9
Successful use of metronomic vinblastine and fluorothymidine pet imaging for the management of intramedullary spinal cord anaplastic oligoastrocytoma in a child.节律性长春花碱和氟胸苷PET成像在儿童脊髓间变性少突星形细胞瘤治疗中的成功应用。
Curr Oncol. 2014 Dec;21(6):e790-3. doi: 10.3747/co.21.2147.
10
Advances in the treatment of neurofibromatosis-associated tumours.神经纤维瘤病相关肿瘤治疗的进展。
Nat Rev Clin Oncol. 2013 Nov;10(11):616-24. doi: 10.1038/nrclinonc.2013.144. Epub 2013 Aug 13.